January 20, 1999Open Access

Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis

Key Points

Key points are not available for this paper at this time.

Abstract

Plasma levels of IGF-I are higher and plasma levels of IGFBP-3 are lower in patients with lung cancer than in control subjects. If these findings can be confirmed in prospective studies, measuring levels of IGF-I and IGFBP-3 in blood may prove useful in assessing lung cancer risk.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Yu et al. (Wed,) studied this question.

synapsesocial.com/papers/69dc2e5e4f901957bec0fa90 https://doi.org/https://doi.org/10.1093/jnci/91.2.151

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line.1992 · 95 citations
2Insulin-like Growth Factor Binding Protein 3 (IGF-BP3) Inhibits Estrogen-Stimulated Breast Cancer Cell Proliferation1994 · 72 citations
3Epidemiology of Insulin-like Growth Factor-I in Elderly Men and Women: The Rancho Bernardo Study1997 · 242 citations
4Statistical Methods in Cancer Research1980 · 6,728 citations
5Nuclear Localization of Insulin-Like Growth Factor Binding Protein 3 in a Lung Cancer Cell Line1997 · 147 citations

Bookmark

View Full Paper